T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alex L. Greninger, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan S. Robins, David M. Koelle
doi: https://doi.org/10.1101/2021.03.19.21251426
Rebecca Elyanow
1Adaptive Biotechnologies, Seattle, Washington, USA
Thomas M. Snyder
1Adaptive Biotechnologies, Seattle, Washington, USA
Sudeb C. Dalai
1Adaptive Biotechnologies, Seattle, Washington, USA
2Stanford University School of Medicine, Stanford, California, USA
Rachel M. Gittelman
1Adaptive Biotechnologies, Seattle, Washington, USA
Jim Boonyaratanakornkit
3Department of Medicine, University of Washington, Seattle, Washington, USA
4Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
Anna Wald
3Department of Medicine, University of Washington, Seattle, Washington, USA
4Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
5Department of Epidemiology, University of Washington, Seattle, Washington, USA
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Stacy Selke
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Mark H. Wener
5Department of Epidemiology, University of Washington, Seattle, Washington, USA
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Chihiro Morishima
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Alex L. Greninger
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
Michael R. Holbrook
7National Institute of Allergy and Infectious Diseases Integrated Research Facility, Frederick, Maryland, USA
Ian M. Kaplan
1Adaptive Biotechnologies, Seattle, Washington, USA
H. Jabran Zahid
8Microsoft Research, Redmond, Washington, USA
Jonathan M. Carlson
8Microsoft Research, Redmond, Washington, USA
Lance Baldo
1Adaptive Biotechnologies, Seattle, Washington, USA
Thomas Manley
1Adaptive Biotechnologies, Seattle, Washington, USA
Harlan S. Robins
1Adaptive Biotechnologies, Seattle, Washington, USA
David M. Koelle
3Department of Medicine, University of Washington, Seattle, Washington, USA
4Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
6Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA
9Department of Global Health, University of Washington, Seattle, Washington, USA
10Benaroya Research Institute, Seattle, Washington, USA
Data Availability
T-cell repertoire profiles and antigen annotation data from the multiplexed antigen-stimulation experiments will be available as part of the ImmuneCODE data resource (Nolan 2020), and can be downloaded from the Adaptive Biotechnologies immuneACCESS site under the immuneACCESS Terms of Use at https://clients.adaptivebiotech.com/pub/covid-2020.
Posted March 22, 2021.
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alex L. Greninger, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan S. Robins, David M. Koelle
medRxiv 2021.03.19.21251426; doi: https://doi.org/10.1101/2021.03.19.21251426
T-cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibody titers and disease severity
Rebecca Elyanow, Thomas M. Snyder, Sudeb C. Dalai, Rachel M. Gittelman, Jim Boonyaratanakornkit, Anna Wald, Stacy Selke, Mark H. Wener, Chihiro Morishima, Alex L. Greninger, Michael R. Holbrook, Ian M. Kaplan, H. Jabran Zahid, Jonathan M. Carlson, Lance Baldo, Thomas Manley, Harlan S. Robins, David M. Koelle
medRxiv 2021.03.19.21251426; doi: https://doi.org/10.1101/2021.03.19.21251426
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (695)
- Anesthesia (186)
- Cardiovascular Medicine (2809)
- Dermatology (241)
- Emergency Medicine (424)
- Epidemiology (12499)
- Forensic Medicine (10)
- Gastroenterology (796)
- Genetic and Genomic Medicine (4364)
- Geriatric Medicine (398)
- Health Economics (711)
- Health Informatics (2813)
- Health Policy (1042)
- Hematology (372)
- HIV/AIDS (888)
- Medical Education (411)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4132)
- Nursing (219)
- Nutrition (613)
- Oncology (2178)
- Ophthalmology (616)
- Orthopedics (253)
- Otolaryngology (316)
- Pain Medicine (260)
- Palliative Medicine (80)
- Pathology (482)
- Pediatrics (1166)
- Primary Care Research (480)
- Public and Global Health (6720)
- Radiology and Imaging (1475)
- Respiratory Medicine (893)
- Rheumatology (427)
- Sports Medicine (359)
- Surgery (468)
- Toxicology (57)
- Transplantation (197)
- Urology (173)